<DOC>
	<DOC>NCT00242450</DOC>
	<brief_summary>During the first 7 days of life very small babies will receive the drug metoclopramide or a salt solution through an intravenous line. They will also begin to receive a very small amount of breast milk or formula within the first 72 hours of life, in addition toother nourishment that is provided by an intravenous line, according to standard hospital procedure. We think that the babies who receive the medication may reach full oral feeds than babies who receive the salt solution.</brief_summary>
	<brief_title>Metoclopramide Use in Very Low Birth Weight Newborns</brief_title>
	<detailed_description>Clinically stable, premature babies (birth weight between 500 and 1,250g) will be randomized to receive metoclopramide (0.1 mg/kg IV q8h)or an equal volume of placebo for 7 days.A transition feeding schedule will begin within the first 72 hours of life. The time to full feeds for the 2 groups will be analyzed.</detailed_description>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>birth weight 500 to 1,250g clinically stable no contraindications to initiating minimal enteral feeding birth weight &gt; 1,250g clinically unstable any major congenital anomaly significant GI pathology severe IUGR cholestasis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>metoclopramide</keyword>
	<keyword>feeding</keyword>
	<keyword>very low birthweightnewborn</keyword>
</DOC>